| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.15M | 41.62M | 45.38M | 44.91M | 34.78M | 25.45M |
| Gross Profit | 19.28M | 41.14M | 45.30M | 44.08M | 33.52M | 24.10M |
| EBITDA | 9.53M | 11.86M | 13.71M | 14.98M | 11.73M | 7.83M |
| Net Income | 8.60M | 9.11M | 9.25M | 11.34M | 8.63M | 5.35M |
Balance Sheet | ||||||
| Total Assets | 41.12M | 42.40M | 36.06M | 36.74M | 33.23M | 33.09M |
| Cash, Cash Equivalents and Short-Term Investments | 11.38M | 13.30M | 17.48M | 14.50M | 17.26M | 19.78M |
| Total Debt | 13.69M | 7.11M | 185.00K | 979.00K | 1.33M | 638.00K |
| Total Liabilities | 13.32M | 13.33M | 7.11M | 8.45M | 7.29M | 6.29M |
| Stockholders Equity | 27.81M | 29.06M | 28.95M | 28.29M | 25.93M | 26.80M |
Cash Flow | ||||||
| Free Cash Flow | 6.66M | 4.86M | 12.24M | 11.21M | 10.99M | 6.45M |
| Operating Cash Flow | 8.90M | 7.35M | 13.05M | 12.44M | 11.40M | 6.87M |
| Investing Cash Flow | 2.95M | 7.09M | -3.36M | 7.04M | -3.51M | -6.51M |
| Financing Cash Flow | -9.30M | -10.58M | -10.43M | -13.04M | -11.53M | -7.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £182.02M | 5.84 | 12.06% | 8.15% | 1.29% | 11.17% | |
74 Outperform | £346.97M | 12.13 | 31.92% | 3.21% | 20.46% | 9.72% | |
72 Outperform | £95.58M | 7.57 | 30.24% | 8.61% | -11.43% | -17.65% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £116.89M | 21.20 | 1.79% | 3.29% | -9.37% | ― | |
64 Neutral | £142.13M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
62 Neutral | £142.43M | 11.98 | 17.51% | 17.93% | -16.53% | -44.15% |